Search Results - "Fazekas, T."

Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD by Hildebrandt, G C, Fazekas, T, Lawitschka, A, Bertz, H, Greinix, H, Halter, J, Pavletic, S Z, Holler, E, Wolff, D

“…This consensus statement established under the auspices of the German working group on BM and blood stem cell transplantation (DAG-KBT), the German Society of…”
Get full text

The prognostic value of serum MMP-7 levels in prostate cancer patients who received docetaxel, abiraterone, or enzalutamide therapy by Szarvas, T., Csizmarik, A., Váradi, M., Fazekas, T., Hüttl, A., Nyirády, P., Hadaschik, B., Grünwald, V., Tschirdewahn, S., Shariat, S.F., Sevcenco, S., Maj-Hes, A., Kramer, G.

“…•High MMP-7 serum level was validated as a predictor of DOC treatment mCRPC patients.•Increasing MMP-7 serum levels during DOC therapy are associated with…”
Get full text

Development and validation of novel self-report questionnaire about the assessment of adolescents’ relation to medicines use and risk by Klimaszová, Z., Fazekaš, T., Kuželová, M.

“…Abstract Adolescents have a lack of experience, knowledge of medicines, which often leads to incorrect use of medicines. Slovak adolescents' attitude towards…”
Get full text

Exhaled nitric oxide and pulmonary complications after paediatric stem cell transplantation by Fazekas, T., Eickhoff, P., Lawitschka, A., Knotek, B., Pötschger, U., Peters, C.

“…Pulmonary complications are major causes of morbidity and mortality after haematopoietic stem cell transplantation (HSCT). We hypothesise that elevated exhaled…”
Get full text

Long-term remission in pediatric Wegener granulomatosis following allo-SCT after reduced-intensity conditioning by Lawitschka, A, Peters, C, Seidel, M G, Havranek, A, Heitger, A, Fazekas, T, Gueclue, E D, Gadner, H, Matthes-Martin, S

Get full text

Non-atopic IgE and eosinophil cationic protein after allogeneic hematopoietic stem cell transplantation in children by Fazekas, T., Pruckner, N., Lawitschka, A., Seidel, M. G., Eickhoff, P., Pötschger, U., Szépfalusi, Z., Gadner, H., Peters, C.

“…Allogeneic hematopoietic stem cell transplantation (HSCT) in childhood is associated with severe pulmonary complications, but the pathophysiologic mechanisms…”
Get full text

Cytokines, chemokines and gene expresion patterns in BAL fluid of children after stem cell transplantation by Fazekas, T, Matthes, S, Lawitschka, A, Attarbaschi, A, Diakos, C, Eickhoff, P, Gadner, H, Fritsch, G, Peters, C

Get full text

Short cognitive screening in elderlies as a part of advanced pharmaceutical care in Slovak community pharmacies - The pilot study KOGNIMET-SK by Mačeková, Z., Krivošová, M., Fazekaš, T., Snopková, M., Klimas, J.

“…Abstract The aim of this study is to evaluate the implementation of a simple, easy-to-use cognitive screening test in the pharmaceutical care of elderly…”
Get full text

Elapsed treatment days--a critical item for radiotherapy quality control review in head and neck trials: RTOG report by Pajak, T F, Laramore, G E, Marcial, V A, Fazekas, J T, Cooper, J, Rubin, P, Curran, Jr, W J, Davis, L W

“…For all randomized trials since 1978, the Radiation Therapy Oncology Group has required the study chairman for radiation therapy to review the treatment given…”
Get more information

A1029 - Lymphovascular invasion as prognostic factor in patients with T1 high-grade non-muscle-invasive bladder cancer by Laukhtina, E., Klemm, J., Fazekas, T., Matsukawa, A., Gontero, P., Soria, F., Babjuk, M., Teoh, J.Y-C., Moschini, M., Karakiewicz, P.I., Abufaraj, M., Comperat, E., Shariat, S.F.

Get full text

Impact of risk factors on oncologic outcomes in intermediate-risk non-muscle-invasive bladder cancer by Laukhtina, E., Klemm, J., Fazekas, T., Matsukawa, A., Gontero, P., Soria, F., Babjuk, M., Teoh, J.Y-C., Moschini, M., Karakiewicz, P.I., Abufaraj, M., Comperat, E., Shariat, S.F.

Get full text

Lymphovascular invasion as prognostic factor in patients with T1 high-grade non-muscle-invasive bladder cancer by Laukhtina, E., Klemm, J., Fazekas, T., Matsukawa, A., Gontero, P., Soria, F., Babjuk, M., Teoh, J.Y-C., Moschini, M., Karakiewicz, P.I., Abufaraj, M., Comperat, E., Shariat, S.F.

Get full text

A0737 - Impact of risk factors on oncologic outcomes in intermediate-risk non-muscle-invasive bladder cancer by Laukhtina, E., Klemm, J., Fazekas, T., Matsukawa, A., Gontero, P., Soria, F., Babjuk, M., Teoh, J.Y-C., Moschini, M., Karakiewicz, P.I., Abufaraj, M., Comperat, E., Shariat, S.F.

Get full text

Is gentamicin administered to individual patients in optimal doses already at the beginning of therapy? by Göböová, M., Vaňo, I., Kissová, V., Fazekaš, T., Kuželová, M.

“…Abstract Introduction A gentamicin dose, which the physicians select, frequently does not take any pharmacokinetic parameters into consideration. Aim To…”
Get full text

A0640 - Evaluation of cardiovascular events among men with prostate cancer treated with androgen receptor signaling inhibitors: A systematic review, meta-analysis, and network meta-analysis by Matsukawa, A., Yanagisawa, T., Rajwa, P., Bekku, K., Mehdi Kardoust, P., Laukhtina, E., Klemm, J., Chiujdea, S., Fazekas, T., Mori, K., Kimura, S., Miki, J., Kimura, T., Shariat, S.

Get full text

P298 - Comparing the performance of digital rectal examination and PSA as a screening test for prostate cancer: A systematic review and meta-analysis by Matsukawa, A., Yanagisawa, T., Bekku, K., Parizi, M.K., Laukhtina, E., Klemm, J., Chiujdea, S., Keiichiro, M., Kimura, S., Fazekas, T., Miszczyk, M., Miki, J., Kimura, T., Karakiewicz, P., Rajwa, P., Shariat, S.

Get full text

Comparing the performance of digital rectal examination and PSA as a screening test for prostate cancer: A systematic review and meta-analysis by Matsukawa, A., Yanagisawa, T., Bekku, K., Parizi, M.K., Laukhtina, E., Klemm, J., Chiujdea, S., Keiichiro, M., Kimura, S., Fazekas, T., Miszczyk, M., Miki, J., Kimura, T., Karakiewicz, P., Rajwa, P., Shariat, S.

Get full text

Evaluation of cardiovascular events among men with prostate cancer treated with androgen receptor signaling inhibitors: A systematic review, meta-analysis, and network meta-analysis by Matsukawa, A., Yanagisawa, T., Rajwa, P., Bekku, K., Mehdi Kardoust, P., Laukhtina, E., Klemm, J., Chiujdea, S., Fazekas, T., Mori, K., Kimura, S., Miki, J., Kimura, T., Shariat, S.

Get full text

A1164 - Molecular analysis of urothelial carcinoma to predict the efficacy of immune checkpoint inhibitor therapy by Váradi, M., Horváth, O., Fazekas, T., Csizmarik, A., Módos, O., Széles, Á., Kenessey, I., Reis, H., Oláh, C., Hadaschik, B., Krafft, U., Ting, S., Furka, A., Nyirády, P., Szarvas, T.

Get full text

Molecular analysis of urothelial carcinoma to predict the efficacy of immune checkpoint inhibitor therapy by Váradi, M., Horváth, O., Fazekas, T., Csizmarik, A., Módos, O., Széles, Á., Kenessey, I., Reis, H., Oláh, C., Hadaschik, B., Krafft, U., Ting, S., Furka, A., Nyirády, P., Szarvas, T.

Get full text